Health & Safety Industry Today

Neurology Clinical Trials Market Grows from 5.6 Billion in 2024 to 10.59 Billion by 2034 Driven by Rising Healthcare Demand

Driven by the rising prevalence of neurological disorders such as Alzheimer’s and Parkinson’s, the market is witnessing increased investment in innovative therapies. Clinical trials in neurology are expanding globally, fueled by advances in diagnostics, personalized medicine, and an aging population seeking better treatment options.
Published 02 December 2025

Polaris Market Research has published a brand-new report titled Neurology Clinical Trials Market Size, Share, Trends, Industry Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Indication, By Value Chain, By Region – Market Forecast, 2025–2034 that includes extensive information and analysis of the industry dynamics. The opportunities and challenges in the report's dynamical trends might be useful for the worldwide Neurology Clinical Trials industry.

The study provides an outline of the market's foundation and organizational structure and forecasts an increase in market share. The study offers a comprehensive analysis of the Neurology Clinical Trials Market size, present revenue, regular deliverables, share, and profit projections. The study report includes a sizable database on future market forecasting based on an examination of previous data.

Neurology Clinical Trials Market Size:

The global neurology clinical trials market is valued at USD 5.60 billion in 2024. The market is expected to grow steadily as the number of neurological disorders continues to rise worldwide. With a projected CAGR of 6.6% from 2025 to 2034, the market is anticipated to reach USD 10.59 billion by 2034. Growing investments in innovative treatments and advanced clinical research methods are key factors driving this expansion.

Figure out what’s there in this deal| Get a glimpse through a sample at –

https://www.polarismarketresearch.com/industry-analysis/neurology-clinical-trials-market/request-for-sample 

Brief About the Report

The market's supply-side and demand-side Neurology Clinical Trials Market trends are evaluated in the study. The study provides important details on applications and statistics, which are compiled in the report to provide a market prediction. Additionally, it offers thorough explanations of SWOT and PESTLE analyses depending on changes in the region and industry. It sheds light on risks, obstacles, and uncertainties, as well as present and future possibilities and challenges in the market.

Neurology Clinical Trials Market – Key Aspects Covered

  • Advancement in neurotherapeutics and biologics
  • Phase-wise and indication-based clinical trial segmentation
  • Patient recruitment challenges and regulatory considerations
  • Growing prevalence of neurological disorders driving demand
  • Competitive landscape including CROs and pharma companies
  • Technology integration in trial design such as AI and remote monitoring
  • Regional analysis of clinical trial hubs and investments

Neurology Clinical Trials Market Segmentation Analysis

The study offers a thorough analysis of the numerous market segments, including application type, product component, service types, and several geographic locations. The report's segment analysis section contains thoroughly researched expert-verified industry data. Strategic recommendations are given in terms of key business segments based on market estimations.

Neurology Clinical Trials Market Size, By Region, 2020 - 2034 (USD Billion)

List of Major Key Players

  • Biogen
  • Charles River Laboratories
  • Eisai Co., Ltd.
  • ICON plc
  • IQVIA
  • Laboratory Corporation of America Holdings
  • Medpace Holdings, Inc.
  • Parexel
  • Pfizer Inc.
  • Syneos Health
  • Thermo Fisher Scientific

Buy Full Research Report

https://www.polarismarketresearch.com/buy/5406/0

Leading Players Analysis

The research report's chapter is entirely devoted to the competition environment. The Neurology Clinical Trials Market key players are examined, analyzing information on their evaluation and development in addition to a quick review of the company. Understanding the techniques employed by businesses and the steps they have recently taken to combat intense rivalry allows one to examine the competitive landscape. It covers each player's company profiles comprising sales, revenue, share, recent developments, SWOT analysis, capacity, production, revenue, gross margin, growth rate, and strategies employed by the major market players.

Different potentials in the domestic and regional markets are revealed by regional analysis of the sector. Each regional industry associated with this market is carefully examined to determine its potential for growth in the present and the future. Moreover, information on recent mergers and acquisitions that have taken place in the market is the subject of the research. This section provides important financial information about mergers and acquisitions that have recently shaped the Neurology Clinical Trials industry.

Regional Analysis

Further, the report goes on to discuss how the Neurology Clinical Trials Market has grown internationally and across various sectors and regions. The regional analysis included in the study provides information at the regional as well as national level by several market segments. Additionally, the study includes information on the origins of raw materials, downstream consumers, and industrial chain analyses. The forecast analysis section includes vital information on global production and revenue projection, as well as regional forecasts.

Report Summary

The analysis focuses on the regional forecast by type and application and the Neurology Clinical Trials Market sales and revenue prediction. The research report features data about the target market, such as pricing trends, customer requirements, and competitor analysis. The market growth has been examined using analytical approaches like PESTLE analysis, Porter's Five Forces analysis, feasibility studies, player-specific SWOT analyses, and ROI analyses.

Browse More Information:

https://www.polarismarketresearch.com/industry-analysis/neurology-clinical-trials-market

The Report Provides You Answer to Below Mentioned Question

Q1: What was the global neurology clinical trials market size in 2024?

Ans: The market size was USD 5.60 billion in 2024.

Q2: What CAGR is expected for this market from 2025 to 2034?

Ans: A CAGR of 6.6% is expected during 2025–2034.

Q3: What will be the market value in 2034?

Ans: It is projected to reach USD 10.59 billion by 2034.

Q4: What drives demand for neurology clinical trials?

Ans: The growing number of neurological disorders and new drug research.

Q5: Which phase of clinical trials holds the largest share?

Ans: Phase II and Phase III trials lead due to higher patient participation.

Objectives of the Report

  • To carefully analyze and forecast the size of the market by value and volume.
  • To evaluate the market shares of major segments of the market
  • To explain the development of the industry in different parts of the world.
  • To analyze and study micro-markets in terms of their contributions to the market, their prospects, and individual growth trends.
  • To offer precise and valuable details about factors affecting the Neurology Clinical Trials Market forecasts
  • To provide a meticulous assessment of crucial business strategies used by leading companies.

More Related Reports:

Geriatric Medicines Market

Leukemia Therapeutics Market

Peripheral Vascular Device Market

Psoriasis Drug Market

Nutricosmetics Market

High Performance Composites Market

Heat Exchangers Market

Glaucoma Market

Theranostics Market

Proteomics Market

About Polaris Market Research & Consulting, Inc:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Likhil G

8 The Green Ste 19824,

Dover, DE 19901,

United States

Phone: +1-929 297-9727

Email: sales@polarismarketresearch.com

Web: https://www.polarismarketresearch.com

Follow Us: LinkedIn | Twitter

Other Industry News

Ready to start publishing

Sign Up today!